Uncategorised - European Medical Journal

How Do Breakfast Habits Influence Clinical Depression Risk?

Skipping breakfast is significantly associated with a higher risk of depression, according to a new systematic review and meta-analysis.

Pain Blocking May Not Reduce Inflammation After Liver Surgery

In this randomised prospective study, 72 living liver donors scheduled for right hepatectomy were enrolled and divided into two groups.

Emotional Distress Weakens Immunotherapy Response in Lung Cancer

Emotional distress before treatment is strongly associated with poorer responses to immunotherapy in patients with advanced non-small cell lung cancer (NSCLC), according to new research.

Vitamin D Supplementation Reduces Pain and Disease Activity in Rheumatoid Arthritis

A randomised double-blind trial in Kosovo found that 4,000 IU of vitamin D daily significantly reduced pain and disease activity in rheumatoid arthritis patients after six months of treatment.

Aspirin Not Recommended for Primary Prevention in Older Adults

Study finds no long-term cardiovascular benefit from aspirin in healthy older people, but highlights increased bleeding risk.

Higher Cancer Risk with JAK Inhibitors in Rheumatoid Arthritis Treatment

Researchers analyzed over 6,500 treatment episodes between January 2017 and December 2020, with follow-up through June 2024

Novel Oral Polio Vaccines Show Strong Safety and Immune Response

A Phase 1 USA trial finds novel oral polio vaccines nOPV1 and nOPV3 to be safe, highly immunogenic, and comparable to Sabin-strain vaccines, paving the way for Phase 2 studies.

Real-World Data Reveals Safety Patterns of Biologics in Paediatric IBD

A large safety analysis of infliximab and adalimumab in pediatric inflammatory bowel disease highlights the need for continued postmarketing monitoring, with new concerns emerging for long-term infliximab use.

GLP-1 Receptor Agonists Show Promise in Hidradenitis Suppurativa

By Month 6 (M6), 50–60% achieved at least a one-point improvement across validated HS severity measures.

The Evolving Atopic Dermatitis Treatment Landscape

Experts provide real-life insights and case examples of managing moderate-to-severe atopic dermatitis, sharing their treatment experience with lebrikizumab.